Eversept Partners »

Abivax SA F shares owned by Eversept Partners

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Eversept Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $36M 427k 84.90

More positions owned by Eversept Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
United Therapeutics Corporation (UTHR)
GSK Sponsored Adr (GSK)
Natera (NTRA)
Vera Therapeutics Cl A (VERA)
Syndax Pharmaceuticals (SNDX)
Vaxcyte (PCVX)
Uniqure Nv SHS (QURE)
Hca Holdings (HCA)
Miragen Therapeutics (VRDN)
Zimvie (ZIMV)
Abivax Sa Sponsored Ads (ABVX)
Ionis Pharmaceuticals (IONS)
PerkinElmer (RVTY)
Travere Therapeutics (TVTX)

View all positions for Eversept Partners

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Cormorant Asset Management
Paradigm Biocapital Advisors
Caligan Partners
FMR
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Vestal Point Capital
Adage Capital Partners GP
Baker Bros. Advisors
Farallon Capital Management

View all funds holding Abivax SA F